Q1: 2026-05-07 Earnings Summary EPS of $0.42 misses by $0.29  |  Revenue of $171.17M (0.38% Y/Y) misses by $2.22M Amphastar Pharmaceuticals, Inc. ( AMPH ) Bank of America Global Healthcare Conference 2026 May 13, 2026 6:00 PM EDT Company Participants William Peters - CFO, Executive VP of Finance, Treasurer & Director Tony Marrs - Executive VP of Regulatory Affairs & Clinical Operations Conference Call Participants Jason Gerberry - BofA Securities, Research Division Presentation Jason Gerberry BofA Securities, Research Division Going here with our next company presenter at the BofA Annual Healthcare Conference. My name is Jason Gerberry. I cover pharma and biotech at BofA, and I'm pleased to be introducing Amphastar Pharmaceuticals. And joining us from Amphastar we have Bill Peters, CFO; and Tony Marrs, Executive Vice President, Clinical and Regulatory. So gentlemen, thanks for joining us. William Peters CFO, Executive VP of Finance, Treasurer & Director Thanks for having us. .…